Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study

被引：0

作者：

Grünwald, Frank ^{[1
,8
]}

Kälicke, Thomas ^{[1
]}

Feine, Ulrich ^{[2
]}

Lietzenmayer, Roland ^{[2
]}

Scheidhauer, Klemens ^{[3
]}

Dietlein, Markus ^{[3
]}

Schober, Otmar ^{[4
]}

Lerch, Hartmut ^{[4
]}

Brandt-Mainz, Katja ^{[5
]}

Burchert, Wolfgang ^{[6
]}

Hiltermann, Gerhard ^{[6
]}

Cremerius, Uwe ^{[7
]}

Biersack, Hans-Jürgen ^{[1
]}

机构：

[1] Department of Nuclear Medicine, University of Bonn, Germany

[2] Department of Nuclear Medicine, University of Tübingen, Germany

[3] Department of Nuclear Medicine, University of Cologne, Germany

[4] Department of Nuclear Medicine, University of Münster, Germany

[5] Department of Nuclear Medicine, University of Essen, Germany

[6] Department of Nuclear Medicine, Medical School of Hannover, Germany

[7] Department of Nuclear Medicine, Aachen University of Technology, Germany

[8] Department of Nuclear Medicine, University of Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 1999年 / 26卷 / 12期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1547 / 1552

共 50 条

[21] Malignant lymphomas: Role of fluorine-18 fluorodeoxyglucose positron emission tomography
Talbot, JN
Montravers, F
Grahek, D
Kerrou, K
Younsi, N
EUROCANCER 2002, 2002, : 17 - 19
[22] Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer
Kosuda, S
Kison, PV
Greenough, R
Grossman, HB
Wahl, RL
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (06) : 615 - 620
[23] Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography
Hoekstra, CJ
Hoekstra, OS
Teengs, JP
Postmus, PE
Smit, EF
CLINICAL NUCLEAR MEDICINE, 1999, 24 (07) : 529 - 530
[24] Fluorine-18 fluorodeoxyglucose positron emission tomography for the detection of recurrent gynecologic cancer.
Khan, N
Oriuchi, N
Kanuma, T
Higuchi, T
Miyakubo, M
Endo, K
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S329 - S329
[25] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
Boerner, AR
Weckesser, M
Herzog, H
Schmitz, T
Audretsch, W
Nitz, U
Bender, HG
Mueller-Gaertner, HW
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (03) : 226 - 230
[26] CLINICAL SIGNIFICANCE OF FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR RECURRENT COLORECTAL CANCER
Ishikawa, H.
Watanabe, A.
Ohyama, T.
Mukogawa, T.
Inoue, T.
Kinoshita, S.
Kawai, N.
Nakagawa, K.
Emoto, K.
Ogawa, S.
GUT, 2009, 58 : A86 - A86
[27] 18F fluorodeoxyglucose positron emission tomography in medullary thyroid cancer:: Results of a multicentre study.
Diehl, MS
Risse, JH
Brandt-Mainz, K
Dietlein, M
Bohuslavizki, KH
Matheja, P
Lange, H
Bredow, J
Koerber, C
Gruenwald, F
JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 132P - 132P
[28] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
Boerner, A.R.
Weckesser, M.
Herzog, H.
Schmitz, T.
Audretsch, W.
Nitz, U.
Bender, H.G.
Mueller-Gaertner, H.-W.
European Journal of Nuclear Medicine and Molecular Imaging, 1999, 26 (03): : 226 - 230
[29] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
A. R. Boerner
M. Weckesser
H. Herzog
T. Schmitz
W. Audretsch
U. Nitz
H. G. Bender
H.-W. Mueller-Gaertner
European Journal of Nuclear Medicine, 1999, 26 : 226 - 230
[30] Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study
Casadepax-Soulet, C.
Benali, K.
Crestani, B.
Piekarski, E.
Mahida, B.
Ebstein, E.
Juge, P. -A.
Forien, M.
Dieude, P.
Ottaviani, S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (07) : 1456 - 1462

← 1 2 3 4 5 →